ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers

Relative Bioavailability of LY03010 Compared to Listed Drug

ClinicalTrials.gov ID: NCT04922593

Public ClinicalTrials.gov record NCT04922593. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Evaluate the PK Profiles of LY03010 and Relative Bioavailability at Steady-state of LY03010 Versus INVEGA SUSTENNA in Schizophrenia Patients

Study identification

NCT ID
NCT04922593
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Luye Pharma Group Ltd.
Industry
Enrollment
281 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 12, 2021
Primary completion
Mar 14, 2022
Completion
Apr 14, 2022
Last update posted
Apr 24, 2023

2021 – 2022

United States locations

U.S. sites
9
U.S. states
5
U.S. cities
9
Facility City State ZIP Site status
Collaborative Neuroscience Network, Inc. Garden Grove California 92845
Synergy San Diego Lemon Grove California 91945
CNS Network, LLC Torrance California 90502
Innovative Clinical Research, Inc. Miami Lakes Florida 33016
Uptown Research Institute, LLC Chicago Illinois 60640
Hassman Research Institute Berlin New Jersey 08009
Hassman Research Institute Marlton New Jersey 08053
InSite Clinical Research, LLC DeSoto Texas 75115
Pillar Clinical Research, LLC Richardson Texas 75080

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04922593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2023 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04922593 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →